Models for predicting blood-brain barrier permeation.

Area of Science:

• Neuroscience
• Pharmacology
• Entomology

Background:

• The blood-brain barrier (BBB) is crucial for neural function but hinders brain disease treatments.
• Existing in vitro and in silico models for BBB permeation lack the reliability and efficiency needed for early drug discovery.
• There is a need for cost-effective and time-efficient models to predict drug delivery across the BBB.

Purpose of the Study:

• To evaluate the functional similarity between the grasshopper (Locusta migratoria) brain barrier and the vertebrate blood-brain barrier (BBB).
• To determine the potential of the insect brain barrier as a surrogate model for the vertebrate BBB in drug discovery.
• To address the limitations of current models in meeting the demands of the pharmaceutical industry.

Main Methods:

• Comparative analysis of brain barrier functionality between Locusta migratoria and vertebrates.
• Assessment of the grasshopper brain barrier's properties relevant to drug permeation.
• Validation of the insect model's performance against established BBB models (implied).

Main Results:

• The grasshopper brain barrier exhibits functional similarities to the vertebrate BBB.
• The insect model demonstrates potential as a viable surrogate for BBB studies.
• The Locusta migratoria brain barrier meets the requirements for early-stage drug discovery.

Conclusions:

• The grasshopper brain barrier serves as a functional surrogate for the vertebrate BBB.
• This insect model offers a time- and cost-efficient alternative for drug discovery, overcoming limitations of current methods.
• The Locusta migratoria model can accelerate the development of treatments for brain diseases.